FIND OUT IMPORTANT INFORMATION REGARDING UTERINE FIBROID EMBOLIZATION (UFE)

More than 20 years ago, the first uterine fibroid embolization (UFE) was performed in the U.S. for the treatment of uterine fibroids.1 Although an effective alternative to hysterectomy, this uterine-sparing, minimally invasive option was first met with some skepticism by the medical community. Since then, UFE has grown in popularity—but not without a fight. EvenRead More Read More

Practicing self-care is essential for a woman’s mental, emotional, and physical well-being. And yet, a recent Jean Hailes Women’s Health Survey found that more than one in four women aged 36-50 don’t get enough time to themselves each month.1 Between demands at work and home, finding that “me time” can be tough. It gets evenRead More Read More

It’s well documented in medical literature that women of African descent develop uterine fibroids five to six years earlier and are more than 5 times as likely to have severe symptoms than Caucasian women of a similar family history.1 With the increasing number of women requiring fibroid treatment, hospitals in Kenya have welcomed international doctorsRead More Read More

Uterine fibroids and polycystic ovary syndrome (PCOS) are two common reproductive health concerns for women. Both are hormone-related diseases that can affect the menstrual cycle, incite pelvic pain, and affect fertility. But beyond a few common symptoms and complications, are these two conditions linked? A landmark study found that among African American women, the incidenceRead More Read More

Women with uterine fibroids pay thousands of dollars more each year in health care costs compared to their healthy peers, a collection of studies show.1 Uterine fibroids, a non-cancerous tumor that grows within the muscle tissue of the uterus, affects nearly 70% of white women and more than 80% of black women by age 50.2Read More Read More